4-trifluoromethylsalicylic acid has been researched along with benzoic anhydride in 1 studies
| Studies (4-trifluoromethylsalicylic acid) | Trials (4-trifluoromethylsalicylic acid) | Recent Studies (post-2010) (4-trifluoromethylsalicylic acid) | Studies (benzoic anhydride) | Trials (benzoic anhydride) | Recent Studies (post-2010) (benzoic anhydride) |
|---|---|---|---|---|---|
| 46 | 5 | 23 | 20 | 0 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, DK; Kim, BW; Kim, IS; Koppula, S; Park, JY; Song, SY; Yoon, SH | 1 |
1 other study(ies) available for 4-trifluoromethylsalicylic acid and benzoic anhydride
| Article | Year |
|---|---|
2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Benzoates; Cell Survival; Cyclooxygenase 2; Disease Models, Animal; Drug Design; In Vitro Techniques; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Models, Theoretical; Neuroglia; Neurons; Nitric Oxide; Parkinson Disease; Peptides; Phosphorylation; Salicylates; Signal Transduction | 2020 |